SEC Form 4 reporting owner

Betz Stephen F.

Betz Stephen F. has filed 18 Form 4 transactions reported between December 26, 2025 and September 1, 2026, as Chief Scientific Officer of Crinetics Pharmaceuticals, Inc..

Name as filed: Betz Stephen F.

Open-market buys, 24 mo

None

reported

Open-market sales, 24 mo

$397K

2 lines

Companies

with Form 4 filings

Latest transaction

Sep 1, 2026

transaction date

Roles and reported holdings

CRNXCrinetics Pharmaceuticals, Inc.
Dec 26, 2025 – Sep 1, 2026
Chief Scientific Officer
Held directly137,101 sh as of Mar 16, 2026 · Form 4
24 months: $397K sold

Transaction history

All 18 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

Date	Company	Type	Shares	Price	Value	Owned after	Filing
Sep 1, 2026	CRNXChief Scientific Officer	Disposition to issuerCode D · direct	47,000	$41.21	$1.9M@ $41.21	0	Form 4
Sep 1, 2026	CRNXChief Scientific Officer	Disposition to issuerCode D · direct	65,000	$48.14	$3.1M@ $48.14	0	Form 4
Sep 1, 2026	CRNXChief Scientific Officer	Disposition to issuerCode D · direct	87,000	$41.49	$3.6M@ $41.49	0	Form 4
Sep 1, 2026	CRNXChief Scientific Officer	Disposition to issuerCode D · direct	110,000	$65.36	$7.2M@ $65.36	0	Form 4
Sep 1, 2026	CRNXChief Scientific Officer	Disposition to issuerCode D · direct	77,000	$64.98	$5.0M@ $64.98	0	Form 4
Sep 1, 2026	CRNXChief Scientific Officer	Disposition to issuerCode D · direct	15,000	$61.81	$927K@ $61.81	0	Form 4
Sep 1, 2026	CRNXChief Scientific Officer	Disposition to issuerCode D · direct	85,000	$69.71	$5.9M@ $69.71	0	Form 4
Sep 1, 2026	CRNXChief Scientific Officer	Disposition to issuerCode D · direct	60,000	$62.39	$3.7M@ $62.39	0	Form 4
Sep 1, 2026	CRNXChief Scientific Officer	Disposition to issuerCode D · direct	56,250	$59.81	$3.4M@ $59.81	0	Form 4
Sep 1, 2026	CRNXChief Scientific Officer	Disposition to issuerCode D · direct	74,540	$75.72	$5.6M@ $75.72	0	Form 4
Sep 1, 2026	CRNXChief Scientific Officer	Disposition to issuerCode D · direct	90,514	$83.09	$7.5M@ $83.09	0	Form 4
Sep 1, 2026	CRNXChief Scientific Officer	Disposition to issuerCode D · direct	79,650	$85.00	$6.8M@ $85.00	0	Form 4
Sep 1, 2026	CRNXChief Scientific Officer	Disposition to issuerCode D · direct	58,286	$85.00	$5.0M@ $85.00	79,650	Form 4
Mar 16, 2026	CRNXChief Scientific Officer	Open-market saleCode S · direct	4,241	$37.77	$160K@ $37.77	137,101	Form 4
Mar 16, 2026	CRNXChief Scientific Officer	Open-market saleCode S · direct	6,371	$37.11	$236K@ $37.11	141,342	Form 4
Feb 23, 2026	CRNXChief Scientific Officer	Grant or awardCode A · direct	47,000	—	—	47,000	Form 4
Feb 23, 2026	CRNXChief Scientific Officer	Grant or awardCode A · direct	30,000	—	—	147,713	Form 4
Dec 26, 2025	CRNXChief Scientific Officer	Option exerciseCode M · direct	18,000	$1.91	$34K@ $1.91	117,713	Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.